Rapid Dose Therapeutics Corp (DOSE)

Rapid Dose Therapeutics Corp has recorded no insider trading activity within the past three months. The most recent transaction occurred on June 17, 2019, when a senior officer acquired 800,000 shares valued at 16,000 dollars. Consequently, there is no current data regarding executive buying or selling patterns to report.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: DOSE Exchange: CNX

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Rapid Dose Therapeutics Corp

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

HYLAND, DOUGLAS ALAN Senior Officer of Issuer Officer

Transaction date 17 Jun 2019

Purchase

Price

156.15

Quantity 56,843 -32.1%

Value CA$1,242,260

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-08-27	2019-06-17	B Purchase	HYLAND, DOUGLAS ALAN Senior Officer of Issuer Officer	56,843 -32.1% 156.15 CA$1,242,260	56,843 -32.1%	156.15	CA$1,242,260